OTCMKTS:VODG Vitro Diagnostics (VODG) Stock Price, News & Analysis → RSVP: Charles Payne’s Cash Flow Workshop (From Unstoppable Prosperity) (Ad) Free VODG Stock Alerts $0.40 0.00 (0.00%) (As of 10/15/2020) Add Compare Share Share Today's Range$0.40▼$0.4050-Day Range$0.40▼$0.4052-Week Range$0.13▼$1.04VolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Vitro Diagnostics alerts: Email Address Ad Unstoppable ProsperityRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? It's true.Click here to register for free. About Vitro Diagnostics Stock (OTCMKTS:VODG)Vitro Diagnostics, Inc., doing business as Vitro Biopharma, focuses on the development, manufacture, and distribution of stem cell products and related tools for use in research, drug discovery, and clinical trials in the United States. Its stem cell technology includes cell lines, supporting products, and methods for generation and differentiation of stem cells into products for the treatment of diseases, such as heart disease, arthritis, multiple sclerosis, brain injury, autism, stroke, Parkinson's, and Alzheimer's diseases. The company also offers Tools for Stem Cell and Drug Discovery that provide researchers basic tools needed to advance stem cell technology, including stem cells and their derivatives; media for growth and differentiation of stem cells; and tools for measurement of stem cell quality, potency, and response to toxic agents. In addition, it offers MSC-Gro, a cell culture media product; MSC cell line for the treatment of skeletal muscular conditions, such as tendonitis, ligament injury, osteoarthritis and accelerated bone fracture healing, etc.; and testing and therapies related to endogenous stem cell activation. Further, the company provides diagnostic testing of stem cell activation and determination of stem cell functional status; and cell-based assays for discovery of novel stem cell activation agents and drugs for the treatment of osteoporosis. Vitro Diagnostics, Inc. was founded in 1986 and is based in Golden, Colorado.Read More VODG Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart VODG Stock News HeadlinesMay 24, 2024 | msn.comGlobal in-vitro diagnostics market to grow at CAGR 4.21% by 2028May 2, 2024 | marketwatch.comQuidelOrtho Appoints Abbott Laboratories Executive as Next CEOApril 18, 2024 | msn.comAgilent’s GenetiSure Dx diagnostic test secures IVDR certificationApril 10, 2024 | msn.comFertility clinic blames return of IVF tourism for revenue slump to €8mFebruary 29, 2024 | sfgate.comWhat is IVF? A nurse explains the evolving science and legality of in vitro fertilizationNovember 8, 2023 | msn.comVeracyte and Illumina partner to develop IVD testsOctober 2, 2023 | benzinga.comIn-vitro Diagnostics Packaging Market Dynamics and Growth Progress 2023-2029July 19, 2023 | benzinga.comSaudi Arabia In-Vitro Diagnostics (IVD) Market Analysis 2023-2028 - Increasing Focus on Digitalization Bodes Well for the SectorJune 13, 2023 | finance.yahoo.comGermany In-Vitro Diagnostics Market Report 2023: Sector to Reach $5.11 Billion by 2028 at a 2.5% CAGRJune 13, 2023 | finance.yahoo.comCMTC Helps In-Vitro Diagnostic Substance Manufacturer Expand Their Market with Sales & Marketing SupportMay 17, 2023 | finance.yahoo.comSmart/AI In-Vitro Diagnostics Market 2023 | Exclusive Report on the Latest Revenue and Future Scope - InsightAce AnalyticMay 11, 2023 | marketwatch.comIn Vitro Diagnostics (IVD) Quality Control Market Growth Status and Foresight till 2030May 11, 2023 | marketwatch.comIn Vitro Diagnostics or IVD Market Research, 2030May 5, 2023 | marketwatch.comIn-Vitro Diagnostics (IVD) Packaging Market in 2023: Insights and Strategies | 2030May 5, 2023 | marketwatch.comIn Vitro Diagnostic (IVD) Reagents Market by Product Type and Consumers-2030May 5, 2023 | marketwatch.comIn Vitro Diagnostics(IVD) Market 2023 Witness Sizeable Growth during Forecast Period 2030April 19, 2023 | finance.yahoo.comIn Vitro Diagnostics Market Size is projected to reach USD 149.4 Billion by 2032, Due to the rising incidence of chronic DiseasesApril 8, 2023 | uk.finance.yahoo.comIn Vitro Diagnostics (IVD) Quality Control Global Market Report 2023March 31, 2023 | finance.yahoo.comLatin America Vitro Diagnostic (IVD) Tests Markets, 2022-2023 & 2027: Growth Potential in Reagents, Consumables, Calibrators, and ControlsMarch 31, 2023 | marketwatch.comIn Vitro Diagnostic Reagents Market Analysis: Explosive Growth Opportunity by 2030March 29, 2023 | benzinga.comIndia In-Vitro Diagnostic Reagents Markets, Competition, Forecasts & Opportunities, 2028FFebruary 27, 2023 | marketwatch.comIVD (In Vitro Diagnostic) Testing Market 2023 Size Industry, Current Trends, Demand and Size Share Estimation by 2028 with Top PlayersFebruary 27, 2023 | marketwatch.comIn Vitro Diagnostics (IVD) Market 2023 LATEST [ R and D ] INSIGHTS in Report of 112 Pages till 2028February 18, 2023 | marketwatch.comIn-Vitro Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Segment Forecast 2023 To 2029January 24, 2023 | benzinga.comGlobal In-Vitro Diagnostics (IVD) Market Report 2022: Sector to Reach $144.7 Billion by 2027 at a 4.6% CAGRSee More Headlines Receive VODG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vitro Diagnostics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/14/2024Today6/09/2024Fiscal Year End10/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biological products, except diagnostic Sub-IndustryN/A Current SymbolOTCMKTS:VODG CUSIPN/A CIK793171 Webwww.vitrobiopharma.com Phone303-999-2130Fax469-633-0088EmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)($2.36) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-5,360,000.00 Net Margins-495.26% Pretax Margin-495.26% Return on Equity-1,020.38% Return on Assets-130.81% Debt Debt-to-Equity RatioN/A Current Ratio0.20 Quick Ratio0.27 Sales & Book Value Annual Sales$1.76 million Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesDr. James R. Musick (Age 73)Chairman, CEO & Pres Mr. John R. Evans (Age 65)CFO & Director Mr. Keith V. BurgeSr. Director of Sales & MarketingKey CompetitorsAdvanced Life SciencesOTCMKTS:ADLSAlvotechNASDAQ:ALVOAVAX TechnologiesOTCMKTS:AVXTClarus TherapeuticsOTCMKTS:CRXTQEntera BioNASDAQ:ENTXView All Competitors VODG Stock Analysis - Frequently Asked Questions How have VODG shares performed in 2024? Vitro Diagnostics' stock was trading at $0.40 at the beginning of the year. Since then, VODG shares have increased by 0.0% and is now trading at $0.40. View the best growth stocks for 2024 here. How were Vitro Diagnostics' earnings last quarter? Vitro Diagnostics, Inc. (OTCMKTS:VODG) announced its earnings results on Thursday, March, 14th. The company reported ($1.03) earnings per share for the quarter. The company had revenue of $0.42 million for the quarter. Vitro Diagnostics had a negative trailing twelve-month return on equity of 1,020.38% and a negative net margin of 495.26%. What other stocks do shareholders of Vitro Diagnostics own? Based on aggregate information from My MarketBeat watchlists, some companies that other Vitro Diagnostics investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), Akero Therapeutics (AKRO), CymaBay Therapeutics (CBAY), Cumberland Pharmaceuticals (CPIX), Entasis Therapeutics (ETTX), Evelo Biosciences (EVLO), Kaleido Biosciences (KLDO). How do I buy shares of Vitro Diagnostics? Shares of VODG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:VODG) was last updated on 6/9/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredJeff Bezos & 48 Members of Congress Are Buying ONE Sector…Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Con...InvestorPlace | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vitro Diagnostics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vitro Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.